Join our daily newsletter At The Bell to receive exclusive market insights
- BetaShares is planning to launch its Digital Health and Telemedicine ETF (EDOC) by the end of the month
- The company believes COVID-19 has accelerated demand for digital health services as public health orders required patients to consult health-care professionals remotely
- EDOC will provide investors with exposure of up to 50 leading global healthcare and telemedicine companies
- This includes companies such as Boston Scientific, Abbott and Resmed
- It will be the company’s 12th addition to its thematic ETF range.
BetaShares is planning to launch its Digital Health and Telemedicine ETF (EDOC) by the end of the month.
The company believes COVID-19 has accelerated demand for digital health services as public health orders required patients to consult healthcare professionals remotely.
However, despite physical health services being widely available again, patients are still accessing digital healthcare services due to convenience, accessibility, and cost-effectiveness.
The EDOC ETF will provide investors with exposure to up to 50 leading global healthcare and telemedicine companies. This includes companies such as Boston Scientific, Abbott and Resmed.
Chief Executive Officer Alex Vynokur said the ETF will give investors a chance to access a diversified portfolio of digital health companies.
“We believe digital healthcare is a long-term secular growth story – enabling more convenient, comprehensive and efficient care for patients,” he said.
“Global spending on healthcare is set to grow as the global population ages and income levels rise.
“Digital healthcare solutions are forecast to be a significant part of this increased spending as technological innovation reduces costs, improves quality and expands access to healthcare for millions across the globe.”
EDOC will be the company’s 12th addition to its thematic ETF range.
